Covid-19 manufacturing roundup: Catalent, AstraZeneca defend vaccine batch quality in safety row — FT; US buys more Covid-19 antibody supplies
AstraZeneca and key manufacturing partner Catalent are defending the quality of the Covid-19 vaccine being distributed in Europe, reports the
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
